Cogent Biosciences Stock 346% Surge Fueled by New Stake
A Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
Learn which commodities offer high returns to enhance your investment portfolio. Make informed decisions to grow your wealth.
26,939 articlesA Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
BitGo’s Q1 2026 earnings reveal more than headline numbers. This guide translates the transcript into actionable insi...
Dividend stocks paused last week as Crown Castle and AT&T tumbled while Coca-Cola rose. The move highlights a cooling...
Tesla sits around $445 as Q1 margin gains meet AI roadmap momentum, prompting fresh Buy, Sell or Hold questions for i...
In 2022, the market dropped hard, but some dividend-focused funds held up better than the broad index. This article e...
A trio of midstream dividend ETFs yielding more than 5% are delivering market-beating performance, offering both inco...
Small, nearly unknown biotech stocks can surge when their pipeline milestones hit. This guide breaks down how to spot...
Quantum computing could reshape many industries, but is IonQ stock your ticket to millionaire status? This guide expl...
QuantumScape faces a volatile path from lab breakthroughs to mass production. This guide breaks down what the stock d...
Cerebras burst onto the public market with a splashy IPO, but a strong first day doesn’t guarantee long-term gains. T...
Runlayer closed a $30 million Series A led by FELICIS with Khosla Ventures joining, bringing total funding to $42 mil...
Nvidia just beat earnings expectations, yet the stock fell in the following days. This article breaks down what the p...